Gene therapy for Parkinson's disease: a decade of progress supported by posthumous contributions from volunteer subjects

被引：9
作者：
Bartus, Raymond T. [1 ,2 ,3 ,4 ]
机构：
[1] RTBioconsultants Inc, San Diego, CA 92130 USA
[2] EVP, San Diego, CA USA
[3] CSO, San Diego, CA USA
[4] Ceregene Inc, San Diego, CA USA
来源：
Neural Regeneration Research | 2015年 / 10卷 / 10期
关键词：
CONTROLLED-TRIAL; DOUBLE-BLIND; NEURTURIN; DELIVERY;
D O I：
10.4103/1673-5374.167783
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1586 / 1588
页数：3
相关论文
共 9 条
[1]   Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC [J].
Bankiewicz, Krystof S. ;
Forsayeth, John ;
Eberling, Jamie L. ;
Sanchez-Pernaute, Rosario ;
Pivirotto, Philip ;
Bringas, John ;
Herscovitch, Peter ;
Carson, Richard E. ;
Eckelman, William ;
Reutter, Bryan ;
Cunningham, Janet .
MOLECULAR THERAPY, 2006, 14 (04) :564-570
[2]   Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies [J].
Bartus, R. T. ;
Kordower, J. H. ;
Johnson, E. M., Jr. ;
Brown, L. ;
Kruegel, B. R. ;
Chu, Y. ;
Baumann, T. L. ;
Lang, A. E. ;
Olanow, C. W. ;
Herzog, C. D. .
NEUROBIOLOGY OF DISEASE, 2015, 78 :162-171
[3]   Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy [J].
Bartus, Raymond T. ;
Weinberg, Marc S. ;
Samulski, R. Jude .
MOLECULAR THERAPY, 2014, 22 (03) :487-497
[4]   Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating "clinical proof-of-concept" for AAV-neurturin (CERE-120) in Parkinson's disease [J].
Bartus, Raymond T. ;
Baumann, Tiffany L. ;
Brown, Lamar ;
Kruegel, Brian R. ;
Ostrove, Jeffrey M. ;
Herzog, Christopher D. .
NEUROBIOLOGY OF AGING, 2013, 34 (01) :35-61
[5]   Bioactivity of AAV2-Neurturin Gene Therapy (CERE-120): Differences Between Parkinson's Disease and Nonhuman Primate Brains [J].
Bartus, Raymond T. ;
Herzog, Christopher D. ;
Chu, Yaping ;
Wilson, Alistair ;
Brown, Lamar ;
Siffert, Joao ;
Johnson, Eugene M., Jr. ;
Olanow, C. Warren ;
Mufson, Elliott J. ;
Kordower, Jeffrey H. .
MOVEMENT DISORDERS, 2011, 26 (01) :27-36
[6]   Disease duration and the integrity of the nigrostriatal system in Parkinson's disease [J].
Kordower, Jeffrey H. ;
Olanow, C. Warren ;
Dodiya, Hemraj B. ;
Chu, Yaping ;
Beach, Thomas G. ;
Adler, Charles H. ;
Halliday, Glenda M. ;
Bartus, Raymond T. .
BRAIN, 2013, 136 :2419-2431
[7]   Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial [J].
Marks, William J., Jr. ;
Bartus, Raymond T. ;
Siffert, Joao ;
Davis, Charles S. ;
Lozano, Andres ;
Boulis, Nicholas ;
Vitek, Jerrold ;
Stacy, Mark ;
Turner, Dennis ;
Verhagen, Leonard ;
Bakay, Roy ;
Watts, Raymond ;
Guthrie, Barton ;
Jankovic, Joseph ;
Simpson, Richard ;
Tagliati, Michele ;
Alterman, Ron ;
Stern, Matthew ;
Baltuch, Gordon ;
Starr, Philip A. ;
Larson, Paul S. ;
Ostrem, Jill L. ;
Nutt, John ;
Kieburtz, Karl ;
Kordower, Jeffrey H. ;
Olanow, C. Warren .
LANCET NEUROLOGY, 2010, 9 (12) :1164-1172
[8]   Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease [J].
Mittermeyer, Gabriele ;
Christine, Chadwick W. ;
Rosenbluth, Kathryn H. ;
Baker, Suzanne L. ;
Starr, Philip ;
Larson, Paul ;
Kaplan, Paul L. ;
Forsayeth, John ;
Aminoff, Michael J. ;
Bankiewicz, Krystof S. .
HUMAN GENE THERAPY, 2012, 23 (04) :377-381
[9]   Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial [J].
Olanow, C. Warren ;
Bartus, Raymond T. ;
Baumann, Tiffany L. ;
Factor, Stewart ;
Boulis, Nicholas ;
Stacy, Mark ;
Turner, Dennis A. ;
Marks, William ;
Larson, Paul ;
Starr, Phillip A. ;
Jankovic, Joseph ;
Simpson, Richard ;
Watts, Ray ;
Guthrie, Barton ;
Poston, Kathleen ;
Henderson, Jaimie M. ;
Stern, Matthew ;
Baltuch, Gordon ;
Goetz, Christopher G. ;
Herzog, Christopher ;
Kordower, Jeffrey H. ;
Alterman, Ron ;
Lozano, Andres M. ;
Lang, Anthony E. .
ANNALS OF NEUROLOGY, 2015, 78 (02) :248-257
1